Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Esmolol for Surgical Field Visibility in Lumbar Discectomy
NCT04260685Phase 2
Key facts
- Status
- Completed
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Countries
- 1
- Sponsor
- Zagazig University
- Modality
- Small Molecules
- Conditions
- lumbar disc herniation (LDH)
01
Overview
Phase 2, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in lumbar disc herniation (LDH) (2 arms), sponsored by Zagazig University. Primary endpoints: Quality of surgical field visibility and Mean Arterial Blood Pressure. Started Feb 2020; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Lidocaine
Lidocaine bolus and infusion
Esmolol
Esmolol bolus and infusion
03
Endpoints
Primary
Quality of surgical field visibility
Mean Arterial Blood Pressure
Secondary
Heart Rate
Simplified Postoperative Nausea and Vomiting
Surgeon Satisfaction
The need for blood transfusion
Amount of blood loss
Beyond the preview
Go deeper on NCT04260685.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04260685.